Basic Information
| LncRNA/CircRNA Name | MIAT |
| Synonyms | NA |
| Region | GRCh38_22:26646428-26676475 |
| Ensemble | ENSG00000225783 |
| Refseq | NR_003491 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qRT-PCR, Western blot |
| Sample | CCA tissues,cell lines (HuCCT-1, RBE, HCCC-9810, QBC939) |
| Expression Pattern | up-regulated |
| Function Description | MIAT was frequently overexpressed in CCA. MIAT contributed to the growth of CCA cells by targeting miR-551b-3p/CCND1 axis. |
| Pubmed ID | 32064660 |
| Year | 2020 |
| Title | Long non-coding RNA MIAT promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis |
External Links
| Links for MIAT | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |